BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 5406361)

  • 41. Early combined hormonal and chemotherapy for metastatic prostatic carcinoma.
    Servadio C; Mukamel E; Lurie H; Nissenkorn I
    Urology; 1983 May; 21(5):493-5. PubMed ID: 6857889
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Total perineal prostatectomy in 398 patients with prostatic carcinoma].
    Belt E; Schröder FH
    Urologe; 1970 Mar; 9(2):65-8. PubMed ID: 5437058
    [No Abstract]   [Full Text] [Related]  

  • 43. Cancer of the prostate.
    N Engl J Med; 1968 Apr; 278(15):848-9. PubMed ID: 5642506
    [No Abstract]   [Full Text] [Related]  

  • 44. [Resorption and effectiveness of implanted compressed hormones in carcinoma of the prostate].
    Ziesche HW
    Urol Int; 1965; 20(5):289-304. PubMed ID: 5863979
    [No Abstract]   [Full Text] [Related]  

  • 45. Bone marrow metastases from prostatic cancer-marked cytolytic effect after only a few days of treatment with diethylstilbestrol.
    Bjøorneklett A; Stavem P; Ly B; Egeberg O
    Scand J Haematol; 1976 Sep; 17(3):227-30. PubMed ID: 968453
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Scalene node excision biopsy in advanced prostate carcinoma.
    Sy FA; Gursel EO; Veenema RJ; Buda J
    J Surg Oncol; 1974; 6(1):61-5. PubMed ID: 4819358
    [No Abstract]   [Full Text] [Related]  

  • 47. Effect of hormones on the growth of virus-transformed hamster prostatic tissue.
    Fraley EE; Paulson DF
    Surg Forum; 1968; 19():544-5. PubMed ID: 4304976
    [No Abstract]   [Full Text] [Related]  

  • 48. [Rate of survival in prostatic cancer with bone metastasis].
    Kuntz D; Ryckewaert A
    Rev Fr Etud Clin Biol; 1969; 14(6):609-13. PubMed ID: 5824263
    [No Abstract]   [Full Text] [Related]  

  • 49. Night sweats in prostatic cancer.
    Moore CB
    JAMA; 1969 Apr; 208(1):155. PubMed ID: 5818506
    [No Abstract]   [Full Text] [Related]  

  • 50. Enlargement of the supraclavicular lymph nodes as the initial sign of prostatic carcinoma.
    Butler JJ; Howe CD; Johnson DE
    Cancer; 1971 May; 27(5):1055-63. PubMed ID: 5581507
    [No Abstract]   [Full Text] [Related]  

  • 51. Lessons from phase III-trials on the hormonal treatment of prostatic cancer. I: Results of EORTC-trials 30761 and 30762.
    de Voogt HJ; Pavone-Macaluso M; Smith PH; de Pauw M; Suciu S
    Prog Clin Biol Res; 1988; 260():111-7. PubMed ID: 2966403
    [No Abstract]   [Full Text] [Related]  

  • 52. Combination of hormonal and cytostatic treatment for advanced carcinoma of the prostate.
    Servadio C
    Prog Clin Biol Res; 1985; 185A():407-26. PubMed ID: 4034582
    [No Abstract]   [Full Text] [Related]  

  • 53. Comparison of diethylstilbestrol, cyproterone acetate and medroxyprogesterone acetate in the treatment of advanced prostatic cancer: final analysis of a randomized phase III trial of the European Organization for Research on Treatment of Cancer Urological Group.
    Pavone-Macaluso M; de Voogt HJ; Viggiano G; Barasolo E; Lardennois B; de Pauw M; Sylvester R
    J Urol; 1986 Sep; 136(3):624-31. PubMed ID: 2942707
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Carcinoma of prostate. Increased mortality and cardio-vascular complications associated with oestrogen therapy as compared with orchiectomy.
    Gardner AM; Setakis N
    Bristol Med Chir J; 1983 Jul; 98(367):117-9. PubMed ID: 6616292
    [No Abstract]   [Full Text] [Related]  

  • 55. [Hormonal treatment of disseminated cancer of the prostate: results and survival obtained in a series of 60 patients].
    Izquierdo Font AJ; Barnadas Molins A; Germa Lluch JR; Marcuello Gaspar E; López López JJ
    Actas Urol Esp; 1985; 9(3):231-6. PubMed ID: 4036688
    [No Abstract]   [Full Text] [Related]  

  • 56. Result of treatment of patients with stage D1 prostatic carcinoma.
    deKernion JB; Huang MY; Kaufman JJ; Smith RB
    Urology; 1985 Nov; 26(5):446-51. PubMed ID: 4060385
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Response of men with advanced prostatic carcinoma to exogenous administration of testosterone.
    Prout GR; Brewer WR
    Cancer; 1967 Nov; 20(11):1871-8. PubMed ID: 4168724
    [No Abstract]   [Full Text] [Related]  

  • 58. Carcinoma of the prostate.
    Flocks RH
    J Urol; 1969 May; 101(5):741-9. PubMed ID: 5780606
    [No Abstract]   [Full Text] [Related]  

  • 59. Megestrol acetate in relapsed carcinoma of prostate.
    Daniel F; MacLeod PM; Tyrrell CJ
    Br J Urol; 1990 Mar; 65(3):275-7. PubMed ID: 2186841
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prostatic cancer revisited.
    Cosgrove MD; Kaempf MJ
    J Urol; 1976 Jan; 115(1):79-81. PubMed ID: 813018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.